基于干细胞的治疗系统性红血性狼
Maryam Zare Moghaddam1, Mohammad Javad Mousavi2, Somayeh Ghotloo3,4
1Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Journal of translational autoimmunity
|May 13, 2024
概括
使用介质干细胞 (MSC) 和造血干细胞 (HSC) 的干细胞疗法对治疗全身性红斑狼 (SLE) 有望. 这些疗法改善了临床症状和免疫标记,尽管潜在的并发症需要进一步研究.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 类风湿病学 类风湿病学
背景情况:
- 系统性红斑狼 (SLE) 是一种普遍存在的自身免疫性类风湿性疾病.
- 它是由自我耐受性的崩引起的,影响连接组织.
- 干细胞疗法正在成为各种疾病的潜在治疗方法,包括自身免疫性疾病.
研究的目的:
- 审查干细胞治疗在全身性红斑狼 (SLE) 的疗效.
- 研究介质干细胞 (MSC) 和造血干细胞 (HSC) 对SLE的影响.
- 评估SLE患者和动物模型的临床和免疫结果.
主要方法:
- 对SLE.干细胞治疗现有文献的综述.
- 分析涉及介质干细胞 (MSC) 和造血干细胞 (HSC) 的研究.
- 评估来自动物模型和SLE人类患者的数据.
主要成果:
- MSC和HSC疗法在影响脏,肺部,肝脏和骨的SLE临床表现方面有所改善.
- 观察到免疫学参数的显著改善,包括减少的自身抗体 (ANA,dsDNA Abs).
- 检测到免疫细胞比率的变化,有利于Th2和Treg细胞.
结论:
- 介质干细胞 (MSC) 和造血干细胞 (HSC) 移植为SLE患者提供潜在的好处,包括提高疗效,安全性和生存率.
- 尽管有优势,但疾病复发,感染和二次自身免疫性疾病 (SAD) 等并发症需要进一步调查.
- 未来的研究应该专注于解决这些并发症,以优化SLE的干细胞治疗.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


